Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORANGE III trial of preoperative Movicol before partial liver resection
NL-OMON40093Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Aug 2012
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of polyethylene glycol in hepatic disease (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Time to continuous intake of solid food for more than 24 hours. Started Aug 2012; status: active, not recruiting.
02
Drugs
polyethylene glycol
03
Conditions
hepatic disease
Beyond the preview
Go deeper on NL-OMON40093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40093.